Vor Biopharma (VOR) Current Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Current Assets data on file, last reported at $500.8 million in Q1 2026.

• Quarterly Current Assets rose 672.25% year-over-year to $500.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $500.8 million (up 672.25% YoY) and the FY2025 annual result came in at $458.1 million, up 374.69% from the prior year.
• Current Assets rose to $500.8 million in Q1 2026 per VOR's latest filing, from $458.1 million in the prior quarter.
• Across five years, Current Assets topped out at $500.8 million in Q1 2026 and bottomed at $64.8 million in Q1 2025.
• The 5-year median for Current Assets is $164.4 million (2023), against an average of $188.8 million.
• The widest annual swing landed in 2024, when Current Assets tumbled 59.08%; it then jumped 672.25% in 2026.
• Tracing VOR's Current Assets over 5 years: stood at $237.0 million in 2022, then sank by 40.58% to $140.8 million in 2023, then sank by 31.46% to $96.5 million in 2024, then jumped by 374.69% to $458.1 million in 2025, then climbed by 9.32% to $500.8 million in 2026.
• Per Business Quant, the three latest VOR Current Assets figures stand at $500.8 million (Q1 2026), $458.1 million (Q4 2025), and $172.5 million (Q3 2025).

Peer Comparison